Moberg Pharma: Interview with CEO Anna Ljung (video)
Research Interview
2021-02-10
08:46
CEO Anna Ljung gives her view on current affairs and processes for MOB-015 given new financing. We also talked about the strategy and commercialization based on the two clinical results.
MH
Mats Hyttinge
Disclosures and disclaimers